An Accurate Diagnostic & Monitoring Solution
Our diagnostic can achieve the specificity and sensitivity required for the detection of pancreatic cancer at an earlier stage, and allowing for more options for successful treatment. As a monitoring tool, our assay can track the progress or the regression of the disease and be a valuable aid to the clinician for assessing the appropriate form of treatment for each patient.
Detection tools to diagnose pancreatic cancer at early stages is an urgent unmet medical need.
Pancreatic ductal adenocarcinoma (PDAC) accounts for greater than 90% of all pancreatic cancer cases and is notoriously difficult to detect at early stages